Differences in pharmacology of tumor necrosis factor (TNF) antagonists

• প্রধান লেখক: S. Bombardieri (Author), U. Fiocco (Author)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: PAGEPress Publications, 2011-09-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

The commercially available inhibitors of TNF are constituted by two classes of molecules: the soluble receptors (Etanercept: Amgen Inc. Wyeth) and the monoclonal antibodies (Adalimumab: Abbott Laboratories and Infliximab: Centocor, Inc.). The differences in their molecular structure, mechanism of ac...